Phase 1b Study PVSRIPO for Recurrent Malignant Glioma in Children
Clinical trial NCT03043391 · COMPLETED
Trial details
- NCT number
- NCT03043391
- Sponsor
- Istari Oncology, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-07
- Primary completion
- 2022-03-23
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.